Introduction and rapid dissemination of SARS-CoV-2 Gamma Variant of Concern in Venezuela

Infect Genet Evol. 2021 Dec:96:105147. doi: 10.1016/j.meegid.2021.105147. Epub 2021 Nov 17.

Abstract

In less than two years since SARS-CoV-2 emerged, the new coronavirus responsible for COVID-19, has accumulated a great number of mutations. Many of these mutations are located in the Spike protein and some of them confer to the virus higher transmissibility or partial resistance to antibody mediated neutralization. Viral variants with such confirmed abilities are designated by WHO as Variants of Concern (VOCs). The aim of this study was to monitor the introduction of variants and VOCs in Venezuela. A small fragment of the viral genome was sequenced for the detection of the most relevant mutations found in VOCs. This approach allowed the detection of Gamma VOC. Its presence was confirmed by complete genome sequencing. The Gamma VOC was detected in Venezuela since January 2021, and in March 2021 was predominant in the East and Central side of the country, representing more than 95% of cases sequenced in all the country in April-May 2021. In addition to the Gamma VOC, other isolates carrying the mutation E484K were also detected. The frequency of this mutation has been increasing worldwide, as shown in a survey of sequences carrying E484K mutation in GISAID, and was detected in Venezuela in many probable cases of reinfection. Complete genome sequencing of these cases allowed us to identify E484K mutation in association with Gamma VOC and other lineages. In conclusion, the strategy adopted in this study is suitable for genomic surveillance of variants for countries lacking robust genome sequencing capacities. In the period studied, Gamma VOC seems to have rapidly become the dominant variant throughout the country.

Keywords: COVID-19; Mutations; Rapid screening; SARS-CoV-2; Variants of Concern.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / epidemiology*
  • COVID-19 / virology*
  • Genome, Viral
  • Humans
  • Mutation
  • Phylogeny*
  • Polymerase Chain Reaction
  • Prevalence
  • Reinfection / virology
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / pathogenicity
  • Venezuela / epidemiology
  • Whole Genome Sequencing

Supplementary concepts

  • SARS-CoV-2 variants